CVA Family Office’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.5K | Sell |
140
-25
| -15% | -$13.1K | 0.01% | 468 |
|
|
2025
Q1 | $105K | Buy |
165
+11
| +7% | +$6.98K | 0.02% | 383 |
|
|
2024
Q4 | $110K | Buy |
154
+9
| +6% | +$6.41K | 0.02% | 374 |
|
|
2024
Q3 | $152K | Buy |
145
+6
| +4% | +$6.31K | 0.02% | 301 |
|
|
2024
Q2 | $146K | Buy |
139
+1
| +0.7% | +$1.05K | 0.03% | 292 |
|
|
2024
Q1 | $133K | Buy |
138
+1
| +0.7% | +$962 | 0.02% | 312 |
|
|
2023
Q4 | $120K | Buy |
+137
| New | +$120K | 0.02% | 308 |
|
|
2023
Q3 | – | Sell |
-123
| Closed | -$88.4K | – | 784 |
|
|
2023
Q2 | $88.4K | Hold |
123
| – | – | 0.02% | 327 |
|
|
2023
Q1 | $101K | Buy |
123
+3
| +3% | +$2.47K | 0.02% | 309 |
|
|
2022
Q4 | $86.6K | Buy |
120
+5
| +4% | +$3.61K | 0.02% | 305 |
|
|
2022
Q3 | $79K | Buy |
115
+20
| +21% | +$13.7K | 0.02% | 277 |
|
|
2022
Q2 | $56K | Sell |
95
-50
| -34% | -$29.5K | 0.02% | 344 |
|
|
2022
Q1 | $101K | Buy |
145
+50
| +53% | +$34.8K | 0.02% | 255 |
|
|
2021
Q4 | $60K | Buy |
+95
| New | +$60K | 0.01% | 330 |
|
|
2021
Q3 | – | Sell |
-95
| Closed | -$53K | – | 769 |
|
|
2021
Q2 | $53K | Buy |
95
+25
| +36% | +$13.9K | 0.02% | 357 |
|
|
2021
Q1 | $33K | Buy |
+70
| New | +$33K | 0.01% | 325 |
|